SUMMARY A 49 year old man with rheumatoid arthritis developed a proliferative glomerulonephritis with progressive renal impairment during treatment with D-penicillamine. His renal function continued to deteriorate after the drug was stopped but improved after treatment with corticosteroids and azathioprine.
his right optic fundus, and ankle oedema. His haemoglobin was 9-2 g/dl (92 g/l), leucocytes 6800/,l (6-8 x 109/l), and erythrocyte sedimentation rate (ESR) 144 mm/lst h. Plasma urea was 10 mmol/l and creatinine 190 iimol/l. Latex test for rheumatoid factor was strongly positive (titre greater than 1 in 320), but the ANF was only weakly positive (titre 1/5). C3 162 mg/dl (1620 mg/l)-(normal range 650-1300 mg/l) and C4 62 mg/dl (620 mg/l)-(NR 120-320 mg/l) were raised. The 24 h urinary protein was 12*5 g. An electrocardiogram (ECG) showed ischaemic changes in the lateral chest leads. Renal biopsy showed diffuse glomerular lesions with endocapillary cell swelling and occasional capsular adhesions associated with focal sclerosis and reactive extracapillary cell aggregates. In a few lesions collections of foam cells were seen within affected capillary loops, and one lesion showed localised tuft necrosis with deposited nuclear debris. Two small blood vessels were normal on light microscopy.
He was then treated with atenolol, hydralazine, spironolactone, and frusemide until his blood pressure was controlled, at which stage the hydralazine and spironolactone were stopped. During the next three months proteinuria (approx 5 g/24 h) persisted and renal function deteriorated (Fig. 1) 1) , and the ECG reverted to normal. Immunoglobulin and complement levels returned to normal within three months and the ANF titre fell to 1/5 by February 1984. The latex test for rheumatoid factor remained positive. The dose of prednisolone was gradually reduced and by October 1984 he was taking azathioprine (150 mg daily) and prednisolone (10 mg daily). At that time, the plasma urea was 5-6 mmol/l, plasma creatinine 121 iimoUl, and creatinine clearance 65 ml/min. There was 0-9 g proteinuria per 24 h.
Discussion
Patients with RA treated with D-penicillamine may develop proteinuria, which usually resolves when the drug is withdrawn.1 In most cases this is due to an immune complex mediated membranous nephropathy, which improves histologically as proteinuria diminishes and is not usually associated with progressive renal impairment. -5 Proliferative glomerulonephritis is a rare complication of treatment with D-penicillamine. It was initially described in a patient with Wilson's disease6 but since then has occasionally been reported in patients with RA who have either developed a drug induced systemic lupus erythematosus syndrome (SLE),7 necrotising vasculitis,8 9 or Goodpasture's syndrome. 10-12 Rarely it has been seen in patients with RA who have not developed features of additional systemic disease. 13 Our patient is of interest in that he developed a proliferative glomerulonephritis leading to a progressive deterioration in renal function, which continued despite stopping D-penicillamine. He had many features of systemic disease with pleural effusions, ischaemic changes on his ECG, a raised ESR, and progressive retinal lesions despite blood pressure control, but he was atypical in several respects. In contrast with the few reported cases of drug induced SLE with renal impairment7 14 the ANF titre was low (1/5) and complement and immunoglobulin levels were high after renal function had started to deteriorate. It has been suggested that penicillamine induced SLE unlike other drug induced forms is associated with antibody to native DNA rather than single stranded or denatured DNA13 and that in this respect it is similar to the nephritis associated with spontaneously occurring SLE. For this reason it is not surprising that D-penicillamine induced SLE is sometimes associated with marked elevation of the Renal function in our patient continued to deteriorate for six months after stopping Dpenicillamine despite control of his blood pressure. At that stage he was given steroid therapy, azathioprine and dipyridamole, and it is probable that this played a major part in his recovery.
